Millennium Management »

Mink Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Mink Therapeutics (INKT) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Mink Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mink Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mink Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $18k 20k 0.91
2022-12-31 $28k 11k 2.57

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf (IWM)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
NVIDIA Corporation Put Option (NVDA)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Meta Platforms Cl A Call Option (META)
Amazon Put Option (AMZN)
Alphabet Cap Stk Cl A Put Option (GOOGL)
Tesla Motors Put Option (TSLA)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Tr Core S&p500 Etf (IVV)
Advanced Micro Devices Call Option (AMD)
Ishares Tr Msci Emg Mkt Etf Call Option (EEM)
Broadcom (AVGO)

View all positions for Millennium Management

Top funds holding Mink Therapeutics

Vanguard Group
Longbow Finance SA
Renaissance Technologies
Geode Capital Management
BlackRock
Captrust Financial Advisors
HighTower Advisors
Susquehanna International
State Street Corporation
Citadel Advisors
Millennium Management
Goldman Sachs Group
Northern Trust
Tower Research Capital
Wells Fargo & Company

View all funds holding Mink Therapeutics